Cargando…
Profiling the Landscape of Drug Resistance Mutations in Neosubstrates to Molecular Glue Degraders
[Image: see text] Targeted protein degradation (TPD) holds immense promise for drug discovery, but mechanisms of acquired resistance to degraders remain to be fully identified. Here, we used clustered regularly interspaced short palindromic repeats (CRISPR)-suppressor scanning to identify mechanisti...
Autores principales: | Gosavi, Pallavi M., Ngan, Kevin C., Yeo, Megan J. R., Su, Cindy, Li, Jiaming, Lue, Nicholas Z., Hoenig, Samuel M., Liau, Brian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052798/ https://www.ncbi.nlm.nih.gov/pubmed/35505873 http://dx.doi.org/10.1021/acscentsci.1c01603 |
Ejemplares similares
-
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
por: Yamanaka, Satoshi, et al.
Publicado: (2023) -
Activity-based CRISPR scanning uncovers allostery in DNA methylation maintenance machinery
por: Ngan, Kevin Chun-Ho, et al.
Publicado: (2023) -
PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates
por: Shimizu, Nobuyuki, et al.
Publicado: (2021) -
Thalidomide and its metabolite 5‐hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF
por: Yamanaka, Satoshi, et al.
Publicado: (2021) -
Rational Chemical Design of Molecular Glue Degraders
por: Toriki, Ethan S., et al.
Publicado: (2023)